Snapchat users share fury at upcoming fees for storing old photos and videos

California's new AI law, championed by Governor Gavin Newsom, has made significant changes by removing the controversial 'kill switch' while implementing essential guardrails for users and companies. This legislation is crucial as it aims to foster innovation in artificial intelligence while ensuring safety and accountability, striking a balance that could serve as a model for other states.

California's new AI law, championed by Governor Gavin Newsom, has made significant changes by removing the controversial 'kill switch' while implementing essential guardrails for users and companies. This legislation is crucial as it aims to foster innovation in artificial intelligence while ensuring safety and accountability, striking a balance that could serve as a model for other states.

Zelda Williams has spoken out against AI-generated videos of her late father, Robin Williams, highlighting the disturbing trend of digital necromancy. This issue raises important questions about the ethical implications of using generative AI to create lifelike representations of deceased individuals, sparking a broader conversation about consent and the legacy of those who have passed away.

Zelda Williams has spoken out against AI-generated videos of her late father, Robin Williams, highlighting the disturbing trend of digital necromancy. This issue raises important questions about the ethical implications of using generative AI to create lifelike representations of deceased individuals, sparking a broader conversation about consent and the legacy of those who have passed away.

Owners of Chinese-built ships are facing significant challenges as US port fees and an estimated $3 billion in costs loom ahead. This situation is critical because it could impact shipping operations and profitability, leading to potential increases in consumer prices and disruptions in supply chains. The financial burden on these owners raises concerns about the broader implications for international trade and the economy.

Owners of Chinese-built ships are facing significant challenges as US port fees and an estimated $3 billion in costs loom ahead. This situation is critical because it could impact shipping operations and profitability, leading to potential increases in consumer prices and disruptions in supply chains. The financial burden on these owners raises concerns about the broader implications for international trade and the economy.

Vanguard has made headlines by significantly reducing fees on six of its ETFs, reinforcing its status as a leader in low-cost investment options. This move not only benefits current investors by lowering their costs but also attracts new investors looking for affordable ways to grow their portfolios. In an industry where fees can eat into returns, Vanguard's commitment to keeping costs low is a game-changer that could influence competitors to follow suit.

Vanguard has made headlines by significantly reducing fees on six of its ETFs, reinforcing its status as a leader in low-cost investment options. This move not only benefits current investors by lowering their costs but also attracts new investors looking for affordable ways to grow their portfolios. In an industry where fees can eat into returns, Vanguard's commitment to keeping costs low is a game-changer that could influence competitors to follow suit.

Mizuho has lowered its stock price target for Shift4 Payments due to international headwinds affecting the company's performance. This adjustment reflects concerns about the challenges Shift4 may face in global markets, which could impact its growth and profitability. Investors should pay attention to these developments as they could influence the stock's future trajectory.

RBC Capital has raised its price target for Select Medical's stock to $20, citing recent regulatory relief as a key factor. This adjustment reflects growing confidence in the company's future performance and highlights the positive impact of regulatory changes on its operations. Investors may see this as a promising sign for Select Medical's growth potential.

Mizuho has lowered its price target for Corteva's stock to $78 following the company's announcement of a stock split. This adjustment reflects concerns about the potential impact of the split on investor confidence and market performance. Investors should pay attention to how this change might affect Corteva's stock in the coming months, as it could influence trading strategies and overall market sentiment.

Zenas Biopharma has successfully licensed three promising autoimmune candidates from InnoCare, marking a significant step forward in their development pipeline. This collaboration not only enhances Zenas's portfolio but also underscores the growing importance of innovative treatments in the autoimmune space. The partnership is expected to accelerate research and bring new therapies to patients in need, highlighting the potential for improved health outcomes.

Frontline stock has received a reaffirmed 'Buy' rating from BTIG, reflecting confidence in the company's performance amid a robust tanker market. This endorsement is significant as it highlights the potential for growth and profitability in the shipping sector, which is currently benefiting from increased demand and favorable market conditions.

In a remarkable achievement, Yoshio Kitagawa, David Robson, and Omar Yaghi have been awarded the 2025 Nobel Prize in Chemistry for their groundbreaking work in the field of porous materials. This recognition not only highlights their innovative contributions but also underscores the importance of chemistry in addressing global challenges such as energy storage and environmental sustainability. Their research paves the way for future advancements that could significantly impact various industries and improve our daily lives.